in vitro transcription (IVT) production and bottling service for mRNA drug-like substance material
Summary
The National Institute of Standards and Technology (NIST) seeks a sole‑source contract to produce and bottle in‑vitro transcription (IVT) mRNA drug‑like substance material as a certified reference standard for the biomanufacturing industry. The effort is critical because only CellScript, LLC holds the patented licensing rights needed to create this modified‑uridine mRNA reference material, which supports quality control and regulatory submissions for mRNA therapeutics.